Key Details
Price
$0.17Annual ROE
-2221.90%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 08, 2023Recent annual earnings:
Mar 28, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Mar 08, 2023Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
British lender Lloyds is closing 136 branches as its customers choose digital financing services. The closures will affect 61 Lloyds branches as well as 61 Halifax and 14 Bank of Scotland locations between May this year and March 2026, the Financial Times (FT) reported Wednesday (Jan. 29).
Key Findings Highlight Continued Growth in Programmatic Advertising, Shift from Linear TV to CTV, and Emphasis on Privacy-Centric Strategies Key Findings Highlight Continued Growth in Programmatic Advertising, Shift from Linear TV to CTV, and Emphasis on Privacy-Centric Strategies
Summit Therapeutics' stock rose 888% since September 2023, driven by positive Phase 3 data for ivonescimab showing superior PFS vs Keytruda in NSCLC. Phase 3 HARMONi-2 trial showed 11.14 vs 5.82 months PFS benefit over Keytruda, with OS data expected in first half of 2025. Company has strong cash position ($486.9M) but faces increased burn rate with multiple Phase 3 trials ongoing.
The stock market, including the Dow Jones, powered higher Friday. The inauguration of Donald Trump and Netflix earnings now loom.
The Securities and Exchange Commission reached a $750,000 settlement with Shift4 Payments, resolving allegations that the payments-technology company failed to make required disclosures in several of its filings.
Philip Morris International aims to be 66% smoke-free by 2030, leveraging high-margin smoke-free products to mitigate regulatory risks and boost profits. PM's acquisition of Swedish Match and US IQOS rights enhances its smoke-free product portfolio, targeting significant growth in nicotine pouches and heated tobacco units. PM's financials show strong revenue growth and expanding operating margins, with a 4.5% dividend yield and plans to reinstate buybacks post-deleveraging by 2026.
BMO Capital analyst Andrew Strelzik initiated coverage on Primo Brands Corp PRMB with an Outperform Rating and announced a price target of $40.00.
C3.ai stock rebounded from the 10-week line to start the new year. The post AI Stock Rebounds From Key Level Amid 'Phase 3' AI Shift In 2025; Is C3.ai A Buy?
The days of individual price action in the financial market are long gone, as one asset class like stocks, bonds, or commodities used to move independently without much pressure from others. However, the past few decades have changed all that, especially as more participants join the stock market and data becomes available nearly instantly in the palm of investors' hands.
Acme United's Strategic Shift Makes It A Compelling Buy
FAQ
- What is the primary business of Shift Technologies?
- What is the ticker symbol for Shift Technologies?
- Does Shift Technologies pay dividends?
- What sector is Shift Technologies in?
- What industry is Shift Technologies in?
- What country is Shift Technologies based in?
- When did Shift Technologies go public?
- Is Shift Technologies in the S&P 500?
- Is Shift Technologies in the NASDAQ 100?
- Is Shift Technologies in the Dow Jones?
- When was Shift Technologies's last earnings report?
- When does Shift Technologies report earnings?
- Should I buy Shift Technologies stock now?